Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesDepression Impairs Executive Functioning in Parkinson Disease Patients With Low Educational Level
Cognitive and Behavioral Neurology, 09/11/09
Kummer A et al. – Patients with PD present with cognitive impairment even when nondemented. Depression may exacerbate executive dysfunction, especially in subjects with lower educational level.
Related Articles
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09
Relevance Score: 70%
Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09
Relevance Score: 69%
Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09
Relevance Score: 69%
Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease
Parkinsonism & Related Disorders, 10/29/09
Relevance Score: 68%
Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS
Parkinsonism & Related Disorders, 10/29/09
Relevance Score: 68%
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuropsychiatric aspects of treated Wilson's disease
Parkinsonism & Related Disorders, 12/09/09
Central Levodopa Influx and the Clinical Motor Response to Levodopa in Patients With Parkinson Disease Complicated With Motor Fluctuations and Dyskinesias
Clinical Neuropharmacology, 12/09/09
Levodopa-Induced Dyskinesias in Parkinson Disease Are Independent of the Extent of Striatal Dopaminergic Denervation: A Pharmacological and SPECT Study
Clinical Neuropharmacology, 12/09/09
Sponsor
Article Search
Sponsor